Vedolizumab Reveals Prolonged-Term Safety, Efficacy
The gut-selective ?4?7 integrin antibody vedolizumab is safe and effective for prolonged-term employ in patients with inflammatory bowel disease (IBD), in step with data from more than 2200 patients in the GEMINI LTS trial. With a median cumulative exposure of…